473 related articles for article (PubMed ID: 34091443)
21. Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease.
Gertje EC; Pluta J; Das S; Mancuso L; Kliot D; Yushkevich P; Wolk D
J Alzheimers Dis; 2016 Oct; 54(3):1027-1037. PubMed ID: 27567809
[TBL] [Abstract][Full Text] [Related]
22. Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.
Varon D; Barker W; Loewenstein D; Greig M; Bohorquez A; Santos I; Shen Q; Harper M; Vallejo-Luces T; Duara R;
Int J Geriatr Psychiatry; 2015 Feb; 30(2):192-200. PubMed ID: 24816477
[TBL] [Abstract][Full Text] [Related]
23. Exploration of neuroanatomical characteristics to differentiate prodromal Alzheimer's disease from cognitively unimpaired amyloid-positive individuals.
Kim HH; Kwon MJ; Jo S; Park JE; Kim JW; Kim JH; Kim SE; Kim KW; Han JW
Sci Rep; 2024 May; 14(1):10083. PubMed ID: 38698190
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
25. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
26. Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
Teipel S; Grothe MJ;
J Alzheimers Dis; 2016 Apr; 52(4):1443-51. PubMed ID: 27079707
[TBL] [Abstract][Full Text] [Related]
27. Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI.
Petrone PM; Casamitjana A; Falcon C; Artigues M; Operto G; Cacciaglia R; Molinuevo JL; Vilaplana V; Gispert JD;
Alzheimers Res Ther; 2019 Aug; 11(1):72. PubMed ID: 31421683
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
29. Feasibility and acceptance of simultaneous amyloid PET/MRI.
Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
Schmand B; Huizenga HM; van Gool WA
Psychol Med; 2010 Jan; 40(1):135-45. PubMed ID: 19863841
[TBL] [Abstract][Full Text] [Related]
31. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
[TBL] [Abstract][Full Text] [Related]
32. Early amygdala and ERC atrophy linked to 3D reconstruction of rostral neurofibrillary tau tangle pathology in Alzheimer's disease.
Stouffer KM; Chen C; Kulason S; Xu E; Witter MP; Ceritoglu C; Albert MS; Mori S; Troncoso J; Tward DJ; Miller MI;
Neuroimage Clin; 2023; 38():103374. PubMed ID: 36934675
[TBL] [Abstract][Full Text] [Related]
33. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.
Vos S; van Rossum I; Burns L; Knol D; Scheltens P; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Handels R; L'Italien G; van der Flier W; Aalten P; Teunissen C; Barkhof F; Blennow K; Wolz R; Rueckert D; Verhey F; Visser PJ
Neurobiol Aging; 2012 Oct; 33(10):2272-81. PubMed ID: 22264648
[TBL] [Abstract][Full Text] [Related]
34. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
35. Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding.
Stonnington CM; Wu J; Zhang J; Shi J; Bauer Iii RJ; Devadas V; Su Y; Locke DEC; Reiman EM; Caselli RJ; Chen K; Wang Y;
J Alzheimers Dis; 2021; 81(1):209-220. PubMed ID: 33749642
[TBL] [Abstract][Full Text] [Related]
36. An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer's disease.
Yu Q; Mai Y; Ruan Y; Luo Y; Zhao L; Fang W; Cao Z; Li Y; Liao W; Xiao S; Mok VCT; Shi L; Liu J; ;
Alzheimers Res Ther; 2021 Jan; 13(1):23. PubMed ID: 33436059
[TBL] [Abstract][Full Text] [Related]
37. Hippocampal and Amygdalar Morphological Abnormalities in Alzheimer's Disease Based on Three Chinese MRI Datasets.
Wei Y; Huang N; Liu Y; Zhang X; Wang S; Tang X
Curr Alzheimer Res; 2020; 17(13):1221-1231. PubMed ID: 33602087
[TBL] [Abstract][Full Text] [Related]
38. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
39. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer's disease.
Skouras S; Falcon C; Tucholka A; Rami L; Sanchez-Valle R; Lladó A; Gispert JD; Molinuevo JL
Neuroimage Clin; 2019; 22():101777. PubMed ID: 30913531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]